IMP
Process View
regulation of wnt signaling pathway planar cell polarity pathway
Any process that modulates the frequency, rate or extent of Wnt signaling pathway, planar cell polarity pathway.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of wnt signaling pathway planar cell polarity pathway"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| AFF4 | AF4/FMR2 family, member 4 | 0.943 | ||
| AFF1 | AF4/FMR2 family, member 1 | 0.874 | ||
| MSH5 | mutS homolog 5 (E. coli) | 0.565 | ||
| DOT1L | DOT1-like, histone H3 methyltransferase (S. cerevisiae) | 0.427 | ||
| EGFR | epidermal growth factor receptor | 0.340 | ||
| RHOA | ras homolog gene family, member A | 0.324 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.269 | ||
| PARD6A | par-6 partitioning defective 6 homolog alpha (C. elegans) | 0.258 | ||
| MLL | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila) | 0.200 | ||
| CCNT1 | cyclin T1 | 0.192 | ||
| TSG101 | tumor susceptibility gene 101 | 0.188 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.159 | ||
| SMAD2 | SMAD family member 2 | 0.154 | ||
| MYO6 | myosin VI | 0.148 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.134 | ||
| LRRK2 | leucine-rich repeat kinase 2 | 0.133 | ||
| ARHGEF12 | Rho guanine nucleotide exchange factor (GEF) 12 | 0.130 | ||
| RIN1 | Ras and Rab interactor 1 | 0.127 | ||
| CDK9 | cyclin-dependent kinase 9 | 0.113 | ||
| MLLT6 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6 | 0.103 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.101 | ||
| RAPGEF1 | Rap guanine nucleotide exchange factor (GEF) 1 | 0.094 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.091 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.087 | ||
| JAM3 | junctional adhesion molecule 3 | 0.086 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.076 | ||
| JAM2 | junctional adhesion molecule 2 | 0.075 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.071 | ||
| DKK1 | dickkopf homolog 1 (Xenopus laevis) | 0.065 | ||
| LRP6 | low density lipoprotein receptor-related protein 6 | 0.063 | Mouse | |
| SMURF2 | SMAD specific E3 ubiquitin protein ligase 2 | 0.062 | ||
| ZMYND11 | zinc finger, MYND-type containing 11 | 0.058 | ||
| KIAA1033 | KIAA1033 | 0.054 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.053 | ||
| F11R | F11 receptor | 0.053 | ||
| PRKCI | protein kinase C, iota | 0.052 | ||
| DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.051 | ||
| SMURF1 | SMAD specific E3 ubiquitin protein ligase 1 | 0.044 | ||
| ERRFI1 | ERBB receptor feedback inhibitor 1 | 0.043 | ||
| PTPN23 | protein tyrosine phosphatase, non-receptor type 23 | 0.042 | ||
| PRKCZ | protein kinase C, zeta | 0.041 | ||
| PTN | pleiotrophin | 0.040 | ||
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.040 | ||
| PLCB3 | phospholipase C, beta 3 (phosphatidylinositol-specific) | 0.040 | ||
| CREBBP | CREB binding protein | 0.038 | ||
| WASF1 | WAS protein family, member 1 | 0.037 | ||
| SFN | stratifin | 0.036 | ||
| TNS4 | tensin 4 | 0.036 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.034 | ||
| SPRR2A | small proline-rich protein 2A | 0.033 | ||
| ELL2 | elongation factor, RNA polymerase II, 2 | 0.032 | ||
| AMMECR1 | Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 | 0.032 | ||
| CTNNA1 | catenin (cadherin-associated protein), alpha 1, 102kDa | 0.031 | ||
| ABI2 | abl-interactor 2 | 0.031 | ||
| SYNJ2 | synaptojanin 2 | 0.030 | ||
| GRB7 | growth factor receptor-bound protein 7 | 0.029 | ||
| JUB | jub, ajuba homolog (Xenopus laevis) | 0.028 | ||
| SOS1 | son of sevenless homolog 1 (Drosophila) | 0.027 | ||
| CDK6 | cyclin-dependent kinase 6 | 0.026 | ||
| DVL3 | dishevelled, dsh homolog 3 (Drosophila) | 0.026 | ||
| ARHGAP1 | Rho GTPase activating protein 1 | 0.026 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.025 | ||
| IQGAP1 | IQ motif containing GTPase activating protein 1 | 0.023 | ||
| MAPT | microtubule-associated protein tau | 0.021 | ||
| RTKN | rhotekin | 0.020 | ||
| PDCD6IP | programmed cell death 6 interacting protein | 0.020 | ||
| LRSAM1 | leucine rich repeat and sterile alpha motif containing 1 | 0.019 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.019 | ||
| SH2D3A | SH2 domain containing 3A | 0.019 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.018 | ||
| ARHGEF11 | Rho guanine nucleotide exchange factor (GEF) 11 | 0.018 | ||
| LRP2 | low density lipoprotein receptor-related protein 2 | 0.018 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.018 | ||
| WNT3A | wingless-type MMTV integration site family, member 3A | 0.018 | ||
| MUC1 | mucin 1, cell surface associated | 0.018 | ||
| HDAC7 | histone deacetylase 7 | 0.018 | ||
| PXN | paxillin | 0.017 | ||
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.016 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.016 | ||
| SRI | sorcin | 0.016 | ||
| CDON | Cdon homolog (mouse) | 0.016 | ||
| MED26 | mediator complex subunit 26 | 0.016 | ||
| MAP4 | microtubule-associated protein 4 | 0.015 | ||
| APC | adenomatous polyposis coli | 0.014 | ||
| MARK2 | MAP/microtubule affinity-regulating kinase 2 | 0.014 | ||
| GLIS2 | GLIS family zinc finger 2 | 0.014 | ||
| RBBP5 | retinoblastoma binding protein 5 | 0.014 | ||
| SHC3 | SHC (Src homology 2 domain containing) transforming protein 3 | 0.013 | ||
| SYT11 | synaptotagmin XI | 0.013 | ||
| PIK3R3 | phosphoinositide-3-kinase, regulatory subunit 3 (gamma) | 0.013 | ||
| MLLT1 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 1 | 0.013 | Human | |
| AXIN2 | axin 2 | 0.013 | ||
| GSK3B | glycogen synthase kinase 3 beta | 0.013 | ||
| PTK6 | PTK6 protein tyrosine kinase 6 | 0.012 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.012 | ||
| MAP2K6 | mitogen-activated protein kinase kinase 6 | 0.012 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.012 | ||
| FLNB | filamin B, beta | 0.012 | ||
| NCKAP1 | NCK-associated protein 1 | 0.012 | ||
| APPBP2 | amyloid beta precursor protein (cytoplasmic tail) binding protein 2 | 0.011 | ||
| SNW1 | SNW domain containing 1 | 0.011 | ||
| ELL3 | elongation factor RNA polymerase II-like 3 | 0.011 | ||
| SORBS2 | sorbin and SH3 domain containing 2 | 0.011 | ||
| ELL | elongation factor RNA polymerase II | 0.011 | ||
| ANTXR2 | anthrax toxin receptor 2 | 0.011 | ||
| YAP1 | Yes-associated protein 1 | 0.011 | ||
| TNS3 | tensin 3 | 0.011 | ||
| PNMA2 | paraneoplastic antigen MA2 | 0.011 | ||
| PPFIBP2 | PTPRF interacting protein, binding protein 2 (liprin beta 2) | 0.011 | ||
| TP73 | tumor protein p73 | 0.011 | ||
| NFYA | nuclear transcription factor Y, alpha | 0.010 | ||
| PRKAR1A | protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) | 0.010 | ||
| SORBS1 | sorbin and SH3 domain containing 1 | 0.010 | ||
| TLN2 | talin 2 | 0.010 | ||
| SHROOM3 | shroom family member 3 | 0.010 |